Stockscreener 앱 받기
434.31
0.52%
-2.27
시간 외 거래:
434.00
-0.31
-0.07%
Vertex Pharmaceuticals Inc 주식(VRTX)의 최신 뉴스
Insider Sell: Carmen Bozic Sells Shares of Vertex Pharmaceuticals Inc (VRTX) - GuruFocus
Vertex Pharmaceuticals Insider Sold Shares Worth $613,971, According to a Recent SEC Filing - Moomoo
Vertex (VRTX) CSO Mark Bunnage sells 33 shares in pre-set 10b5-1 trade - Stock Titan
Vertex Pharmaceuticals Incorporated (VRTX) Latest Stock News & Headlines - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX) Is a Trending Stock: Facts to Know Before Betting on It - Yahoo! Finance Canada
Vertex Pharma stock (US92532F1003): cystic fibrosis leader after solid quarterly results - AD HOC NEWS
North Dakota State Investment Board Buys Shares of 8,821 Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Canada Post Corp Registered Pension Plan Has $2.94 Million Stake in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock (US92532F1003): focus on cystic fibrosis and expanding pipeline - AD HOC NEWS
Vertex Pharma stock (US92532F1003): institutional flows and pipeline keep focus on biotech heavyweig - AD HOC NEWS
Vertex Pharmaceuticals stock (US92532F1003): gene-editing hopes meet kidney data buzz - AD HOC NEWS
Leuthold Group LLC Boosts Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
STF Management LP Lowers Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated (VX1.DE) Stock Price, News, Quote & History - Yahoo Finance
Vertex Pharmaceuticals Incorporated (VRTX.VI) Stock Price, News, Quote & History - Yahoo Finance
Vertex Pharmaceuticals Incorporated $VRTX Shares Purchased by DNB Asset Management AS - MarketBeat
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat
Allworth Financial LP Has $6.36 Million Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Vertex Pharma stock (US92532F1003): Q1 numbers, ESOP shelf and gene-editing momentum draw investor f - AD HOC NEWS
Vertex Pharmaceuticals (NASDAQ: VRTX) insider files Form 144 to sell vested shares - Stock Titan
Mark Bunnage sells shares at VRTX (NASDAQ: VRTX) in Form 144 filing - Stock Titan
FY2027 Earnings Forecast for VRTX Issued By Erste Group Bank - MarketBeat
Daiwa Securities Adjusts PT on Vertex Pharmaceuticals to $555 From $561, Maintains Buy Rating - marketscreener.com
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by Atria Investments Inc - MarketBeat
Layoff Tracker: Takeda cuts 4,500, Novartis lays off biomedical research staff - BioSpace
Vertex Pharmaceuticals (NASDAQ:VRTX) CMO Carmen Bozic Sells 6,988 Shares - MarketBeat
Vertex (VRTX) CMO Carmen Bozic sells 6,988 shares in planned 10b5-1 trade - Stock Titan
Capital World Investors (NASDAQ: VRTX) reports 10.1% stake in Vertex - Stock Titan
Vertex Pharmaceuticals stock (US92532F1003): Shareholder approval fuels biotech momentum - AD HOC NEWS
Capital Research discloses 21.1M-share stake in Vertex (NASDAQ: VRTX) - Stock Titan
Vertex Pharma stock (US92532F1003): Shares up 1.06% to $453 amid biotech strength - AD HOC NEWS
Vertex Pharmaceuticals posts mixed Q1; investors focus on non-CF pipeline for growth - MSN
Pacer Advisors Inc. Buys 9,641 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Bank Julius Baer & Co. Ltd Zurich Sells 10,154 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Baader Bank Aktiengesellschaft Purchases New Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Fierce Biotech Layoff Tracker 2026: Takeda takes away 4.5K roles; Valneva reduces workforce - Fierce Biotech
Vertex Pharmaceuticals (VRTX) Announces Approval of 2026 Stock a - GuruFocus
5 Must-Read Analyst Questions From Vertex Pharmaceuticals’s Q1 Earnings Call - Yahoo Finance
Vertex Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
Vertex (NASDAQ: VRTX) investors back 2026 stock plan and written consent right - Stock Titan
Vertex Pharma stock (US92532F1003): Rockets 3.77% on strong options volume - AD HOC NEWS
Crossmark Global Holdings Inc. Decreases Stock Position in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Q2 2026 earnings preview - MSN
Carmen Bozic sells 2,329 VRTX shares on 02/27, 03/13 and 03/27 (VRTX) - Stock Titan
Why is Vertex Pharmaceuticals stock rallying today? - Investing.com
Why is Vertex Pharmaceuticals stock rallying today? By Investing.com - Investing.com Canada
Vertex Pharma stock (US92532F1003): Earnings highlight pain drug advances - AD HOC NEWS
Vertex’s Germany CASGEVY Deal Highlights Growing Non CF Growth Story - Yahoo Finance
A year after Vertex’s big launch, pain drug research faces a pivotal moment - BioPharma Dive
Provident Investment Management Inc. Has $67.67 Million Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
SVB Wealth LLC Sells 4,354 Shares of Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals Incorporated $VRTX Position Boosted by NewEdge Wealth LLC - MarketBeat
Vertex to Participate in Upcoming May 2026 Investor Conferences - BioSpace
1 Top Wall Street Analyst Thinks CRISPR Therapeutics Could More Than Double. Should You Buy the Stock Hand Over Fist? - The Motley Fool
Vertex to Participate in Upcoming May Investor Conferences - marketscreener.com
Swiss Life Asset Management Ltd Increases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharma stock (US92532F1003): Latest developments and business overview - AD HOC NEWS
Securian Asset Management Inc. Decreases Stock Holdings in Vertex Pharmaceuticals Incorporated $VRTX - MarketBeat
Vertex Pharmaceuticals (VRTX) Stock Analysis: A Biotech Giant with 27.84% Potential Upside - DirectorsTalk Interviews
Vertex Pharmaceuticals Incorporated $VRTX Shares Acquired by ABN AMRO Bank N.V. - MarketBeat
Top Biotech Stocks To ConsiderMay 10th - MarketBeat
Investors heavily search Vertex Pharmaceuticals Incorporated (VRTX): Here is what you need to know - MSN
Biotech Stocks To Watch NowMay 9th - MarketBeat
Vertex Pharma stock (US92532F1003): Q1 2026 earnings beat lifts shares on growth in new disease area - AD HOC NEWS
Vertex Pharmaceuticals Earnings Call Highlights New Growth Engines - TipRanks
0.10%
자본화:
|
볼륨(24시간):